Rantus Pharma

Hyderabad, India
Manufactures active pharmaceutical ingredients and intermediates.

About Rantus Pharma

Rantus Pharma was a Healthcare company based in Hyderabad (India). It manufactures active pharmaceutical ingredients and intermediates. It operates on a B2B model. The company has 1 employees. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Manufacturing and Active Ingredients. Its legal entity in India is Rantus Pharma Private Limited (U24239TG2003PTC040459). Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.

Company details

Rantus Pharma manufactures active pharmaceutical ingredients and intermediates through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and active ingredients. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Net Loss
    -₹12.7 Lakh

    FY 2019 · 0% margin

  • EBITDA
    -₹5.2 Lakh

    FY 2019 · 0% margin

  • Employee Count
    1

Board of directors of Rantus Pharma Private Limited (Rantus Pharma)

Rantus Pharma Private Limited is the primary company behind Rantus Pharma. The boards of the 2 registered companies of Rantus Pharma currently have 11 directors; the longest-serving is Umamaheswara Rao Kotte, appointed in 2003. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Umamaheswara Rao Kotte
DIN 02114404
Managing Director07 Feb 200323 yrs 8 moRantus Pharma Private Limited
Soudhamini Narravula
DIN 02605499
Director07 Feb 200323 yrs 8 moRantus Pharma Private Limited
Ratna Kumari Kotti
DIN 01192906
Director17 Feb 200323 yrs 7 moRantus Pharma Private Limited
Srinivasareddy Desireddy
DIN 01819852
Director21 Sep 200422 yrsOptimus Pharma Private Limited
Harsha Vardhana Reddy Poluru
DIN 09740319
Director23 Sep 20224 yrsOptimus Pharma Private Limited
Pagadala Baskarannarayanan
DIN 09754875
Director19 Oct 20223 yrs 11 moOptimus Pharma Private Limited
Anil Khubchandani
DIN 09209485
Director26 Jun 20233 yrs 3 moOptimus Pharma Private Limited
Uma Rao
DIN 07810779
Director09 May 20242 yrs 5 moOptimus Pharma Private Limited
Lakshay Kataria
DIN 08345477
Additional Director01 Apr 20251 yr 6 moOptimus Pharma Private Limited
Sumit Mohan Nadgir
DIN 07619675
Director01 Apr 20251 yr 6 moOptimus Pharma Private Limited
Santosh Kumar Mahil
DIN 07584287
Director26 Jun 20251 yr 3 moOptimus Pharma Private Limited

Financials of Rantus Pharma

Figures of Rantus Pharma Private Limited, the primary company behind Rantus Pharma, for FY 2019. Net loss was -₹12.7 Lakh (0% margin). EBITDA was -₹5.2 Lakh (0% margin). Revenue has grown at a compounded annual rate of -100% over three years and -100% over five years.

  • -₹12.7 LakhNet loss · 0% margin
  • -₹5.2 LakhEBITDA · 0% margin
  • ₹2.70 CrPaid-up capital
  • -100%Revenue CAGR, 3 years
  • -100%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Rantus Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Rantus Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Rantus Pharma

Rantus Pharma has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
provepharm.com1998Marseille, France$145.93M–
APIs and drug products are developed and valorized in pharmaceuticals.
biostar-pharm.com2002Beijing, China$135.23M–
APIs, intermediates, and biochemical reagents are developed and manufactured.
sequent.in2002Bengaluru, India––
APIs are developed and manufactured for therapeutic areas.
sterlingpharmasolutions.com2016Dudley, United Kingdom–560
Contract development, manufacturing, and analytical services for APIs are offered.
snapdragonchemistry.com2014Cambridge, United States–43
Drug discovery and development service provider
jubilantpharma.com1978Noida, India––
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
hikal.com1988Mumbai, India–355
APIs and intermediates are produced via custom synthesis and research.
Premium access

Detailed similar companies of Rantus Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Rantus Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Rantus Pharma

Premium access

Complete news archive for Rantus Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rantus Pharma

Rantus Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Rantus Pharma has 1 employees.

Rantus Pharma manufactures active pharmaceutical ingredients and intermediates through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and active ingredients. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Rantus Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

Rantus Pharma is associated with 2 legal entities: Rantus Pharma Private Limited, Optimus Pharma Private Limited.

The legal entities of Rantus Pharma currently have 12 directors, including Srinivasareddy Desireddy, Anil Khubchandani, Lakshay Kataria and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available